IRONWOOD PHARMACEUTICALS INC (IRWD) Stock Price, Quote, News and Overview
NASDAQ:IRWD - Nasdaq - US46333X1081 - Common Stock - Currency: USD
IRWD Quote, Performance and Key Statistics
IRONWOOD PHARMACEUTICALS INC
NASDAQ:IRWD (1/30/2025, 6:04:08 PM)
After market: 2.35 +0.05 (+2.17%)2.3
-1.42 (-38.17%)
The current stock price of IRWD is 2.3 USD. In the past month the price decreased by -47.49%. In the past year, price decreased by -84.24%.
IRWD Latest News, Press Releases and Analysis
Let's take a look at the stocks that are in motion in today's session.
Keep an eye on the top gainers and losers in Thursday's session, as they reflect the most notable price movements.
Top stock movements in today's session.
Keep an eye on the top gainers and losers in Thursday's session, as they reflect the most notable price movements.
There are notable gap-ups and gap-downs in today's session.
Let's have a look at what is happening on the US markets on Thursday. Below you can find the gap up and gap down stocks in today's session.
Curious about the stocks that are showing activity after the closing bell on Wednesday?
After the closing bell on Wednesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.
Ironwood Pharmaceuticals Initiates Apraglutide NDA Submission, Highlights Compelling New Data and Updates Corporate Structure to Position for the Future
Ironwood Pharmaceuticals to Participate in the Piper Sandler 36th Annual Healthcare Conference
IRWD Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 16.34 | 310.40B | ||
| AMGN | AMGEN INC | 14.78 | 152.67B | ||
| GILD | GILEAD SCIENCES INC | 21.88 | 120.83B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 859.61 | 112.90B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.04 | 75.06B | ||
| ARGX | ARGENX SE - ADR | N/A | 39.81B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 35.75B | ||
| BNTX | BIONTECH SE-ADR | N/A | 29.13B | ||
| ONC | BEIGENE LTD-ADR | N/A | 24.16B | ||
| NTRA | NATERA INC | N/A | 23.27B | ||
| BIIB | BIOGEN INC | 8.95 | 21.31B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 16.49B |
Related stock screener links
About IRWD
Company Profile
Ironwood Pharmaceuticals, Inc. is a healthcare company, which engages in the development and commercialization of Gastrointestinal (GI) products. The company is headquartered in Boston, Massachusetts and currently employs 267 full-time employees. The company went IPO on 2010-02-03. The company is engaged in the development of LINZESS (linaclotide) for adults with irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC). Linaclotide is also approved for the treatment of functional constipation in pediatric patients ages 6-17 years old. The company is advancing apraglutide, a long-acting synthetic glucagon-like peptide-2 (GLP-2) analog being developed for rare gastrointestinal diseases, including short bowel syndrome with intestinal failure (SBS-IF) as well as several earlier stage assets. The company is advancing IW-3300, a GC-C agonist, for the potential treatment of visceral pain conditions, such as interstitial cystitis/bladder pain syndrome (IC/BPS), and endometriosis. The company is also developing CNP-104 for the treatment of PBC, a rare autoimmune disease targeting the liver.
Company Info
IRONWOOD PHARMACEUTICALS INC
100 Summer Street, Suite 2300
Boston MASSACHUSETTS 02110 US
CEO: Mark Mallon
Employees: 267
Company Website: https://www.ironwoodpharma.com/
Investor Relations: https://investor.ironwoodpharma.com
Phone: 16176217722
IRWD FAQ
What is the stock price of IRWD?
The current stock price of IRWD is 2.3 USD.
What is the symbol for IRONWOOD PHARMACEUTICALS INC stock?
The exchange symbol of IRONWOOD PHARMACEUTICALS INC is IRWD and it is listed on the Nasdaq exchange.
On which exchange is IRWD stock listed?
IRWD stock is listed on the Nasdaq exchange.
Is IRWD a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for IRWD, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of IRWD.
Does IRWD stock pay dividends?
IRWD does not pay a dividend.
When does IRWD stock report earnings?
IRWD will report earnings on 2025-02-13, after the market close.
What is the Price/Earnings (PE) ratio of IRWD?
IRWD does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.01).
What is the Short Interest ratio of IRWD stock?
The outstanding short interest for IRWD is 5.86% of its float.
IRWD Technical Analysis
IRWD Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to IRWD. IRWD has only an average score on both its financial health and profitability.
IRWD Financial Highlights
Over the last trailing twelve months IRWD reported a non-GAAP Earnings per Share(EPS) of -0.01. The EPS decreased by -101.09% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -0.63% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
IRWD Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 82% to IRWD. The Buy consensus is the average rating of analysts ratings from 12 analysts.
For the next year, analysts expect an EPS growth of -81.67% and a revenue growth -20.22% for IRWD